Format

Send to

Choose Destination
See comment in PubMed Commons below
Neuropharmacology. 2010 Sep-Oct;59(4-5):358-65. doi: 10.1016/j.neuropharm.2010.04.008. Epub 2010 Apr 24.

Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans.

Author information

  • 1Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA.

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and is the most common form of dementia in elderly people. The accumulation of amyloid beta (Abeta) is one of the histopathological hallmarks of AD. Abeta is aggregated to form oligomers which are toxic to neurons and are critical to the onset and progression of AD. In a Caenorhabditis elegans (C. elegans) model of AD, human Abeta is expressed intracellularly in the body wall muscle. The expression and subsequent aggregation of Abeta in the muscle lead to progressive paralysis. Although the mechanism of action is unknown, antidepressants have been used with FDA approved drugs for dementia in AD and have been shown to enhance cognitive function in human and in animal models of AD. We found that the antidepressant fluoxetine, a selective serotonin reuptake inhibitor, significantly delayed Abeta-induced paralysis in the C. elegans model of Abeta toxicity by reducing Abeta oligomers. Our results showed that insulin signaling and DAF-16/FOXO transcription factors were required for fluoxetine-mediated delayed paralysis. We also found that fluoxetine increased thermal stress resistance and extended life span. These findings suggests that fluoxetine may have benefit for the treatment of AD by the reduction of proteotoxicity.

PMID:
20420844
PMCID:
PMC2926186
DOI:
10.1016/j.neuropharm.2010.04.008
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center